DANIEL HEUSINGER: Open Payments
NPI 1710514237 · DUNKIRK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 48 payments from 20 companies in 2025. Trend: 2023 $1,250 · 2024 $1,207 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $125 |
| Merck Sharp & Dohme LLC | 5 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| BridgeBio Pharma, Inc. | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Recor Medical Inc | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Novo Nordisk Inc | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
Products named: JARDIANCE, Attruby, VYNDAQEL, VERQUVO, ELIQUIS, Paradise Ultrasound Renal Denervation System, CAMZYOS, LEQVIO.
Industry payments across NY — which companies pay providers there.
